Please login to the form below

Not currently logged in
Email:
Password:

isotretinoin

This page shows the latest isotretinoin news and features for those working in and with pharma, biotech and healthcare.

Recordati snaps up Swiss pharma company Pro Farma

Recordati snaps up Swiss pharma company Pro Farma

The firm sealed a deal with independent family-owned Swiss firm Pro Farma last week that was valued at CHF16m and will add to its portfolio the acne treatment Tretinac (isotretinoin)

Latest news

  • Therapy focus: acne

    Severe Acne drug. Now, there is a whole host of drugs, including the contraceptive pill and many herbal remedies, but one that has courted particular attention is isotretinoin (Roaccutane and Accutane), ... Treatment with this drug has had a high success

  • Alliance Pharma's profit up 17 per cent

    The products include acne treatment Rizuderm (isotretinoin). The move follows previous acquisitions for Alliance this year, including the pain relief therapy Anbesol (benzocaine).

  • Roche drug slapped with caveats

    The Food and Drug Administration (FDA) said it had approved a strengthened distribution programme for Accutane, also known under its generic name isotretinoin, requiring doctors and patients to register and accept

  • News in brief, April 04, 2007

    The FDA is launching a special webpage to warn consumers about the dangers of buying Accutane (isotretinoin) online.

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Deal Watch July 2016 Deal Watch July 2016

    The product contains isotretinoin (Roaccutane) and has Orphan Drug Designation in the US. ... 50. Patagonia/ Almirall. PAT-001 (isotretinoin-based treatment) – congenital ichthyosis. Licence. 28.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

PANDAS/PANS Awareness: A parent’s story
To help raise awareness of these often underdiagnosed diseases, Jon Hallows, Joint MD at Porterhouse shares his own experience as a parent of a son recently diagnosed with PANDAS...
Iskra Reic
Leading AstraZeneca’s return to growth in Europe
PME talks to Iskra Reic, the company’s head of Europe and Canada...
The era of digital wellbeing
Social media - friend or foe?...

Infographics